FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310707612> ?p ?o ?g. }

• W4310707612 endingPage "7430" @default.
• W4310707612 startingPage "7420" @default.
• W4310707612 abstract "Rationale: Metastatic melanoma is the most aggressive and dangerous form of skin cancer. The introduction of immunotherapy with Immune checkpoint Inhibitors (ICI) and of targeted therapy with BRAF and MEK inhibitors for BRAF mutated melanoma, has greatly improved the clinical outcome of these patients. Nevertheless, response to therapy remains highly variable and the development of drug resistance continues to be a daunting challenge. Within this context there is a need to develop diagnostic tools capable of predicting response or resistance to therapy in order to select the best therapeutic approach. Over the years, accumulating evidence brought to light the role of microRNAs (miRNAs) as disease biomarkers. Methods: In particular, the detection of miRNAs in whole blood or specific blood components such as serum or plasma, allows these molecules to be good candidates for diagnosis, prognosis and for monitoring response to anticancer therapy. In this paper, we evaluated circulating basal levels of 6 previously identified miRNAs in serum samples of 70 BRAF-mutant melanoma patients before starting targeted therapy. Results: Results show that the circulating levels of the oncosuppressor miR-579-3p and of the oncomiR miR-4488 are able to predict progression free survival (PFS) but not overall survival (OS). Most importantly, we observed that the best predictor of disease outcome is represented by the ratio of circulating miR-4488 vs. miR-579-3p (miRatio). Finally, the combination of the Lactate dehydrogenase (LDH) blood levels with the two circulating miRNAs alone or together did not produce any improvement in predicting PFS indicating that miR-579-3p and miR-4488 are independent predictors of PFS as compared to LDH. Conclusions: All together these data underscored the relevance of circulating miRNAs as suitable tools to predict therapy response in melanoma and maybe further developed as companion diagnostics in the clinic." @default.
• W4310707612 created "2022-12-16" @default.
• W4310707612 creator A5000771134 @default.
• W4310707612 creator A5007120604 @default.
• W4310707612 creator A5008092130 @default.
• W4310707612 creator A5025909416 @default.
• W4310707612 creator A5029398339 @default.
• W4310707612 creator A5032495692 @default.
• W4310707612 creator A5040267877 @default.
• W4310707612 creator A5052593572 @default.
• W4310707612 creator A5056211996 @default.
• W4310707612 creator A5060732049 @default.
• W4310707612 creator A5064140780 @default.
• W4310707612 creator A5069839280 @default.
• W4310707612 creator A5070550857 @default.
• W4310707612 creator A5072037953 @default.
• W4310707612 creator A5074732027 @default.
• W4310707612 creator A5075620356 @default.
• W4310707612 creator A5082149678 @default.
• W4310707612 creator A5082689719 @default.
• W4310707612 creator A5084919462 @default.
• W4310707612 creator A5086592438 @default.
• W4310707612 creator A5086743021 @default.
• W4310707612 creator A5089097982 @default.
• W4310707612 date "2022-01-01" @default.
• W4310707612 modified "2023-09-30" @default.
• W4310707612 title "Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma" @default.
• W4310707612 cites W1834835434 @default.
• W4310707612 cites W1974254202 @default.
• W4310707612 cites W1985213644 @default.
• W4310707612 cites W1996963134 @default.
• W4310707612 cites W2019607817 @default.
• W4310707612 cites W2156057678 @default.
• W4310707612 cites W2192681205 @default.
• W4310707612 cites W2220243639 @default.
• W4310707612 cites W2485296348 @default.
• W4310707612 cites W2573690182 @default.
• W4310707612 cites W2597872842 @default.
• W4310707612 cites W2609262625 @default.
• W4310707612 cites W2614807523 @default.
• W4310707612 cites W2725858897 @default.
• W4310707612 cites W2773114641 @default.
• W4310707612 cites W2775456985 @default.
• W4310707612 cites W2783944216 @default.
• W4310707612 cites W2784307064 @default.
• W4310707612 cites W2793817570 @default.
• W4310707612 cites W2802741981 @default.
• W4310707612 cites W2893501387 @default.
• W4310707612 cites W2896600825 @default.
• W4310707612 cites W2899802502 @default.
• W4310707612 cites W2902435990 @default.
• W4310707612 cites W2911662030 @default.
• W4310707612 cites W2911769095 @default.
• W4310707612 cites W2912652373 @default.
• W4310707612 cites W2945549231 @default.
• W4310707612 cites W2949702575 @default.
• W4310707612 cites W2952477354 @default.
• W4310707612 cites W2965555612 @default.
• W4310707612 cites W2976806193 @default.
• W4310707612 cites W2982666253 @default.
• W4310707612 cites W2991007821 @default.
• W4310707612 cites W3001041847 @default.
• W4310707612 cites W3003394374 @default.
• W4310707612 cites W3010560689 @default.
• W4310707612 cites W3012298751 @default.
• W4310707612 cites W3014374354 @default.
• W4310707612 cites W3036983837 @default.
• W4310707612 cites W3037998331 @default.
• W4310707612 cites W3043597140 @default.
• W4310707612 cites W3044892665 @default.
• W4310707612 cites W3048583508 @default.
• W4310707612 cites W3091961646 @default.
• W4310707612 cites W3092368475 @default.
• W4310707612 cites W3093560845 @default.
• W4310707612 cites W3097126295 @default.
• W4310707612 cites W3098849313 @default.
• W4310707612 cites W3137909560 @default.
• W4310707612 cites W3144603271 @default.
• W4310707612 cites W3153157803 @default.
• W4310707612 cites W3157413896 @default.
• W4310707612 cites W3175799242 @default.
• W4310707612 cites W3182981660 @default.
• W4310707612 doi "https://doi.org/10.7150/thno.77761" @default.
• W4310707612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36438490" @default.
• W4310707612 hasPublicationYear "2022" @default.
• W4310707612 type Work @default.
• W4310707612 citedByCount "4" @default.
• W4310707612 countsByYear W43107076122023 @default.
• W4310707612 crossrefType "journal-article" @default.
• W4310707612 hasAuthorship W4310707612A5000771134 @default.
• W4310707612 hasAuthorship W4310707612A5007120604 @default.
• W4310707612 hasAuthorship W4310707612A5008092130 @default.
• W4310707612 hasAuthorship W4310707612A5025909416 @default.
• W4310707612 hasAuthorship W4310707612A5029398339 @default.
• W4310707612 hasAuthorship W4310707612A5032495692 @default.
• W4310707612 hasAuthorship W4310707612A5040267877 @default.
• W4310707612 hasAuthorship W4310707612A5052593572 @default.
• W4310707612 hasAuthorship W4310707612A5056211996 @default.

• next